https://pharkeep.com/tevimbra-tislelizumab-jsgr-nursing-education-guide/
Tevimbra (tislelizumab-jsgr) Nursing Education Guide
Aug 15, 2025 - Tevimbra (tislelizumab-jsgr) Drug Overview Tevimbra is an immune checkpoint inhibitor (PD-1 blocker) used to treat unresectable or metastatic esophageal...
nursing educationguide
https://www.cliniexpert.com/article/949.html
FDA Approves Tevimbra (tislelizumab-jsgr) for the Treatment of Advanced or Metastatic Esophageal...
BeiGene, Ltd. today announced that the FDA has approved Tevimbra (tislelizumab-jsgr) as monotherapy for the treatment of adult patients with unresectable or...